Connection

Michael Hallek to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Combined Modality Therapy.
Michael Hallek
Connection Strength
0.174
Combined Modality Therapy
  1. Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial. Blood. 2016 Jan 14; 127(2):208-15.
    View in: PubMed
    Score: 0.078
  2. Sequential and combination treatments with novel agents in chronic lymphocytic leukemia. Haematologica. 2019 11; 104(11):2144-2154.
    View in: PubMed
    Score: 0.026
  3. Management of unfit elderly patients with chronic lymphocytic leukemia. Eur J Intern Med. 2018 12; 58:7-13.
    View in: PubMed
    Score: 0.024
  4. Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia. Br J Haematol. 2018 12; 183(5):727-735.
    View in: PubMed
    Score: 0.024
  5. Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial. Blood. 2017 09 21; 130(12):1477-1480.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.